Literature DB >> 21948405

Three-dimensional peptide fractionation for highly sensitive nanoscale LC-based shotgun proteomic analysis of complex protein mixtures.

Sricharan Bandhakavi1, Todd W Markowski, Hongwei Xie, Timothy J Griffin.   

Abstract

To sensitively analyze complex protein mixtures by mass spectrometry-based shotgun proteomics, researchers have employed platforms that couple orthogonal peptide fractionation methods using nanoscale HPLC. Commonly used platforms have coupled either strong cation exchange (SCX) HPLC or preparative isoelectric focusing (IEF) with nanoscale reversed-phase (nanoRP) HPLC fractionation of peptides. Coupling two dimensions of peptide fractionation, prior to mass spectrometric analysis, increases the sensitivity for identifying low abundance proteins. However, the large dynamic range of protein abundance and high level of complexity of protein mixtures derived from many biological sources, such as bodily fluids, require additional steps of peptide fractionation. To address this shortcoming, we have developed a platform combining three dimensions of peptide fractionation as follows: (1) preparative IEF; (2) SCX HPLC; and (3) nanoRP HPLC. This platform significantly increases the sensitivity of shotgun proteomic analysis in complex protein mixtures. Here, we describe the implementation of this three-dimensional peptide fractionation platform for proteomic studies of complex mixtures.

Mesh:

Substances:

Year:  2011        PMID: 21948405     DOI: 10.1007/978-1-61779-319-6_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

Review 1.  Metaproteomics of the human gut microbiota: Challenges and contributions to other OMICS.

Authors:  Ngom Issa Isaac; Decloquement Philippe; Armstrong Nicholas; Didier Raoult; Chabrière Eric
Journal:  Clin Mass Spectrom       Date:  2019-06-04

2.  Characterization of the endothelial cell cytoskeleton following HLA class I ligation.

Authors:  Mary E Ziegler; Puneet Souda; Yi-Ping Jin; Julian P Whitelegge; Elaine F Reed
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.